Two separate cannabis bills have been passed by the Washington state Senate. One has to do with the use of medical cannabis in schools and another regards testing cannabis products before they get on the market.
The bill on medical cannabis in schools is intended to help students with chronic illnesses for which they are being treated using medical marijuana. The bill will allow those students to get their medical cannabis treatment while at school.
More specifically, the treatment will be administered by a parent, and not a school official or a nurse. This provision was intended to eliminate any liability issues that can arise from the administration of medical cannabis to students.
Secondly, the stipulation that only parents can administer medical cannabis to their children at school will also remove any issues that could have arisen regarding the licensing of the people administering medical cannabis to kids.
The senate bill also bans smoking medical cannabis on school premises. Students can therefore only receive medical cannabis edibles and other forms of marijuana. Cannabis products whose THC content is high are also banned from school premises. Most medical cannabis plants are carefully bred to have a high CBD content and very low, if any, THC.
The bill has a trigger clause that allows schools in Washington State to suspend accepting medical marijuana for students once the federal government threatens to cut off the funding of the schools over the medical marijuana program.
In a related development, the senate also passed a bill to modify the marijuana testing requirements of the state. This bill looks at various testing parameters, such as potency, mold, and pesticides.
The lawmakers observed that the existing law had gaps which allowed players in the cannabis industry to make some claims that are hard to verify on their product labels.
The bill wants to transfer oversight of cannabis testing labs from the Liquor and Cannabis Board to the Department of Ecology.
If the bill becomes law, the ecology department will be expected to table new testing guidelines in 2020 and 2021. These guidelines will stem the tide of facilities springing up and claiming to be cannabis testing labs.
The two bills had already got the nod from the state Assembly. The “yes” vote from the senate therefore means that the modified bills will be sent back to the House so that the lawmakers there can approve the changes made by the senators. Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) welcome the two bills because they will not only inspire confidence in cannabis products but also make it easy for students to receive their medical cannabis treatment while at school.
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000
For more information please visit https://www.CNW420.com
Do you have a questions or are you interested in working with CNW420? Ask our Editor